Cell administration routes for heart failure: a comparative re-evaluation of the REGENERATE-DCM and REGENERATE-IHD trials. Supplementary tables

Table S1. Baseline characteristics of the REGENERATE-DCM and REGENERATE-IHD trials Table S2. The characteristics of the cells found in the injectate in the individual trials. Table S3. The pooled characteristics of the cells found in the peripheral blood and the injectate. Table S4. Left ventricular ejection fraction and volumes Table S5. Overview of randomised controlled cell therapy trials for heart failure divided by delivery route.表S1. REGENERATE-DCM与REGENERATE-IHD临床试验的基线特征 表S2. 各单项试验中注射制剂所含细胞的特征 表S3. 外周血与注射制剂所含细胞的汇总特征 表S4. 左心室射血分数与心室容积 表S5. 按给药途径分类的心力衰竭随机对照细胞治疗试验概览